Paul A. Friedman
2017 - Synta Pharmaceuticals
In 2017, Paul A. Friedman earned a total compensation of $1.4M as Chief Executive Officer at Synta Pharmaceuticals, a 66% decrease compared to previous year.
Compensation breakdown
| Bonus | $335,000 |
|---|---|
| Salary | $400,000 |
| Stock Awards | $629,424 |
| Other | $558 |
| Total | $1,364,982 |
Friedman received $629.4K in stock awards, accounting for 46% of the total pay in 2017.
Friedman also received $335K in bonus, $400K in salary and $558 in other compensation.
Rankings
In 2017, Paul A. Friedman's compensation ranked 7,462nd out of 14,666 executives tracked by ExecPay. In other words, Friedman earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,462 out of 14,666 | 49th |
Division Manufacturing | 2,785 out of 5,768 | 52nd |
Major group Chemicals And Allied Products | 904 out of 2,074 | 56th |
Industry group Drugs | 706 out of 1,730 | 59th |
Industry Pharmaceutical Preparations | 550 out of 1,329 | 59th |
Source: SEC filing on April 27, 2018.
Friedman's colleagues
We found two more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2017.